- Data can come from hospitals, patients, their family, government initiations, analytics companies, and a myriad of other potential partners
- For robustness, real-world data should come from several sources, allowing it to be translated into evidence to support other projects
- Coordinated co-operation is key to cover as many data sources as possible to fully utilise real-world evidence
Click here to read the source article
SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.